To further validate the role of SPTBN2 in CC patients, we first analyzed the expression of SPTBN2 in TCGA-COAD database, and we found that SPTBN2 was significantly highly expressed in COAD patients and in a variety of cancers (Fig. 7A). Here, SPTBN2 is linked to cancer.